AIDS vaccine efficacy trials: expand capacity and prioritize. 'Throughout Africa, Asia and Latin America state-of-the-art clinics and laboratories...exist where, 4 years ago, there were none'

Expert Rev Vaccines. 2006 Apr;5(2):167-70. doi: 10.1586/14760584.5.2.167.
No abstract available

Publication types

  • Editorial
  • Review

MeSH terms

  • AIDS Vaccines* / therapeutic use
  • Africa / epidemiology
  • Asia / epidemiology
  • Developing Countries
  • Humans
  • Laboratories / trends
  • Latin America / epidemiology
  • Randomized Controlled Trials as Topic / methods*
  • Randomized Controlled Trials as Topic / trends

Substances

  • AIDS Vaccines